Search For "life science"
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 7 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Reactors producing benzimidazole gas caused leakage: Visakhapatnam Police
Updated : 5 years, 8 months ago IST
Visakhapatnam (Andhra Pradesh) [India], June 30 (ANI): The gas leakage incident at Sainor Life Sciences Pvt Ltd in Visakhapatnam occurred on Monday night at about 11:20 pm when the workers in the factory were working on reactors producing benzimidazole gas, said Police on Tuesday.
Read More
Gas leakages a regular feature 'owing to lack of action from Andhra govt',
Updated : 5 years, 8 months ago IST
Amaravati (Andhra Pradesh) [India], June 30 (ANI): Targetting Andhra government over gas leakage at Sainor Life Sciences Pvt Ltd in Visakhapatnam, Telugu Desam Party (TDP) chief N Chandrababu Naidu on Tuesday alleged that gas leakages have become a regular feature owing to "lack of action an
Read More
Andhra CM enquires about gas leak accident in Visakhapatnam factory
Updated : 5 years, 8 months ago IST
Amaravati (Andhra Pradesh) [India], June 30 (ANI): Andhra Pradesh Chief Minister YS Jagan Mohan Reddy enquired about the accident due to gas leakage at Sainor Life Sciences Pvt Ltd at Visakhapatnam's Parawada.
Read More
2 workers died, 4 hospitalised following gas leakage in Visakhapatnam fact
Updated : 5 years, 8 months ago IST
Visakhapatnam (Andhra Pradesh) [India], June 30 (ANI): Two workers died and four were hospitalised on Tuesday after a gas leak occurred in a factory here.
Read More
Biomoneta raises funding to ensure germ-free spaces for all
Updated : 5 years, 9 months ago IST
Bengaluru (Karnataka) [India] June 16 (ANI/PRNewswire): Life sciences startup Biomoneta Research raised seed funding to further the development of its germicidal technology and take it to market.
Read More
A2A Pharmaceuticals collaborates with LAXAI Life Sciences to Co-develop SA
Updated : 5 years, 9 months ago IST
Hyderabad (Telangana) [India], June 9 (ANI/PRNewswire): A2A Pharmaceuticals, a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents announces today an agreement to co-develop SARS-CoV-2 Main Proteases inhibitors for the treatment of
Read More
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More
Extract 48 COVID RNA samples in just 17 Minutes with the latest technology
Updated : 5 years, 9 months ago IST
New Delhi [India], May 27 (ANI/NewsVoir): Premas Life Sciences (PLS) and Genolution (a South Korea based company) have announced a new sales distribution agreement, appointing Premas Life Sciences as technology and knowledge distributor of Nextractor NX-48S Platform in India.
Read More
Codex and Premas Life Sciences partner to launch world's first and only fu
Updated : 5 years, 10 months ago IST
New Delhi [India], May 15 (ANI/NewsVoir): Premas Life Sciences (PLS) and Codex (previously known as SGI-DNA) today announced a new sales distribution agreement, appointing Premas Life Sciences as the exclusive technology and knowledge distributor of Codex's BioXP 3200 Platform in India.
Read More
Jubilant Life Sciences surges 5 pc after signing deal with Gilead for prod
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19.
Read More
Sai Life Sciences joins the global 'COVID Moonshot' project
Updated : 5 years, 10 months ago IST
Hyderabad (Telangana) [India] May 7 (ANI/PRNewswire): Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced its collaboration with the COVID Moonshot project that aims to deliver an antiviral drug candidate effectiv
Read More